Search Saint Luke's

The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.

Consumer Reports On Health talked to Dr. Bethany Austin and Austin Workman about strategies to improve quality of life for those living with heart failure.

Veteran news reporter Dan Verbeck missed the biggest story of his life—his own death.

Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.

Kelly Anspaugh received both a heart and kidney transplant at Saint Luke's.

What should have been a dream getaway became a nightmare when a car accident forced Kelsey O’Connor and her friend off the road and into emergency care in a foreign country.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

FOX4 talked to Dr. Randall Thompson about the decade-long study of ancient mummies.

Dr. James O'Keefe, preventive cardiologist with Saint Luke's Mid America Heart Institute, joins FOX4 to talk about what it is, the pros and cons of intermittent fasting, and who would benefit from it most.